Skip to main content
Top
Published in: Journal of Translational Medicine 1/2010

Open Access 01-11-2010 | Poster presentation

BIK is a novel pro-apoptotic target gene for miR-125b in human monocytes

Authors: I Duroux-Richard, J Presumey, Y M Pers, S Fabre, C H Lecellier, J Gruen, T Häupl, A Grützkau, G Burmester, C Jorgensen, F Apparailly

Published in: Journal of Translational Medicine | Special Issue 1/2010

Login to get access

Excerpt

The high numbers of activated cells in rheumatoid arthritic (RA) joints critically contribute to the persistence of chronic disease and have been associated with their resistance to undergo apoptosis [1]. Activity of pro- and anti-apoptotic Bcl-2 family members is constrained by transcriptional and/or post-transcriptional controls. As part of the post-transcriptional gene regulatory network machinery, micro(mi)RNAs represent an important class of endogenous, short, non-coding RNA that decreases gene expression by pairing to target transcripts and inducing gene silencing. Among miRNAs that have been assigned oncogenic and/or tumor suppressor-like functions, miR-125b is of particular interest. Among the dozen of genes that are identified so far as miR-125b targets, three are directly involved in apoptosis, all encoding for pro-apoptotic proteins: Bmf, BAK1 and p53 [2-4]. …
Literature
1.
go back to reference Hutcheson J, Perlman H: Apoptotic regulators and RA. Current Rheum Reviews. 2008, 4: 254-258. 10.2174/157339708786263870.CrossRef Hutcheson J, Perlman H: Apoptotic regulators and RA. Current Rheum Reviews. 2008, 4: 254-258. 10.2174/157339708786263870.CrossRef
2.
go back to reference Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V: MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 2009, 23 (7): 862-76. 10.1101/gad.1767609.PubMedCentralCrossRefPubMed Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V: MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 2009, 23 (7): 862-76. 10.1101/gad.1767609.PubMedCentralCrossRefPubMed
3.
go back to reference Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH: MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem. 2009, 23 (46): 347-58. 10.1159/000218181.CrossRefPubMed Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH: MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem. 2009, 23 (46): 347-58. 10.1159/000218181.CrossRefPubMed
4.
go back to reference Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y: MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 2010, 285 (28): 21496-507. 10.1074/jbc.M109.083337.PubMedCentralCrossRefPubMed Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y: MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 2010, 285 (28): 21496-507. 10.1074/jbc.M109.083337.PubMedCentralCrossRefPubMed
Metadata
Title
BIK is a novel pro-apoptotic target gene for miR-125b in human monocytes
Authors
I Duroux-Richard
J Presumey
Y M Pers
S Fabre
C H Lecellier
J Gruen
T Häupl
A Grützkau
G Burmester
C Jorgensen
F Apparailly
Publication date
01-11-2010
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue Special Issue 1/2010
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-8-S1-P56

Other articles of this Special Issue 1/2010

Journal of Translational Medicine 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.